Developer docs
API playgroundTry for free, no card

Search company profiles

Zyla Life Sciences

Full company profile

uuid000dyxj

Namestring
Zyla Life Sciences
Legal namestring
AUS Merchant Services, Inc.
Websiteurl
zyla.com
Company typeenum
Private
Founded yearint
1995
Descriptiontext

Zyla, operated by AUS Merchant Services, Inc. (NMLS ID: 1277102), is a US-licensed cross-border money transmitter and multi-currency payments platform headquartered at 525 Almanor Ave, Sunnyvale, CA. The company provides a single core product - the Zyla Account, a multi-currency digital wallet supporting 17+ receiving currencies with local account details and 100+ sending currencies across 210+ countries/territories - extended through specialized modules including 1688 World Pay (a 2025-launched joint product with Alibaba's 1688.com enabling real-time CNY payments to Chinese suppliers), Zyla Enterprise (an API-first institutional FX and payments platform), and six vertical-specific solutions targeting E-commerce/DTC, Digital Entertainment, Airline/Travel, Gig Economy, HR/Payroll, and Financial Institutions. The platform is built on a marketed "AI-native architecture" with a smart pricing engine and integrates directly with 130+ marketplaces including Amazon, TikTok Shop, and AliExpress, while bundling FX risk management tools (spot, forwards, NDFs, rate alerts) and Alipay rails for China-bound payments. Zyla sits within the Ant International ecosystem alongside sister brand WorldFirst and partners Alipay+, Antom, and Bettr, sharing technology infrastructure under common ownership.

The business model is transaction-based with no monthly fees or minimum balances. Revenue is generated through per-transaction fees starting at $1 for US bank transfers, currency conversion spreads up to 0.75%, and a 0.8% standard rate plus tiered fees up to 0.2% on 1688 World Pay flows. The customer base spans 1.5M+ businesses accumulated since 2004, segmented into a long tail of SMB e-commerce sellers, software developers, and agencies (acquired via self-serve PLG with online account opening) and a growing enterprise segment (acquired via direct sales and API integration) including named customers BIPO, Grab, and an SFC-licensed stock trading platform. Distribution combines a self-serve SMB funnel (website, SEO, referral program) with enterprise sales motion targeting financial institutions, HR/payroll platforms, and gig economy platforms, supplemented by banking partner networks for fund safeguarding and global payment routing. The company is a FinCEN-registered Money Services Business with state money transmission licenses, restricted in New York and Nevada.

Note on input data: firmographics describe "Zyla Life Sciences" as a 1995-founded healthcare products company in Wayne, PA, but the entirety of the detailed product, customer, revenue, and operational data describes Zyla, a fintech. The analysis above reflects the fintech entity, which is the only subject with substantive evidence in the source material.

Short descriptiontext

Zyla is a US-licensed cross-border payments platform (AUS Merchant Services, Inc., NMLS 1277102) providing a multi-currency account, FX, and 1688.com supplier payments to 1.5M+ SMB and enterprise customers across 210+ countries, operating within the Ant International ecosystem.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersWayne, United States
HQ citystring
Wayne
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
multi-currency payments, cross-border payments, foreign exchange services, global money transfers, payment platform
Industry4 codes
1Multi-Currency Accounts, Wallets & FX Management (Consumer/SME)
CodeFSAGAKAFPrimaryYes
2Cross-Border & FX Payments Platforms
CodeBPAMAFAKPrimaryNo
3Cross-Border Payment Orchestration & Routing
CodeFSAGAKAJPrimaryNo
4Cross-border Payments, FX & Multi-currency Checkout
CodeCRAFAJAFPrimaryNo
NAICS code1 code
  • Activities Related to Credit Intermediation5223
SIC code1 code
  • Finance Services6199
Product category
Cross-Border Payments
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Transaction Fees
TypeTransaction Fee
Description

Fees charged per payment transaction to US bank accounts, starting as low as $1 per transaction. Free payments to other Zyla Accounts.

zyla.com
2Currency Conversion Spread
TypeTransaction Fee
Description

Revenue generated from the spread between exchange rates offered to customers and rates received by Zyla. Competitive rates for major currencies including CAD, HKD, AUD, and others.

zyla.com
31688 World Pay Fees
TypeTransaction Fee
Description

0.8% standard rate for auto-debit transactions when paying for 1688.com orders, plus tiered service fee up to 0.2% based on monthly transaction volume

zyla.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Pricing details4 tiers
1Multi-currency account with no monthly fees
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free monthly account fees, no subscription fees, no minimum balance requirements. Access to 10+ foreign currencies including USD, CAD, AUD, HKD, SGD, EUR, GBP, JPY, NZD, CNH, MXN.

zyla.com
2Payment fees to US bank accounts
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Starting as low as $1 per transaction to US bank accounts. Free instant payments to other Zyla Accounts.

zyla.com
3Currency conversion with competitive rates
ModelUsage-basedBilling cadencePay-as-you-go
Notes

Currency conversion fees up to 0.75%. Competitive exchange rates for all major currencies. Business funds held with FDIC member banking partners.

zyla.com
41688 World Pay service fees
ModelTransaction based/ take rateBilling cadenceMonthly
Notes

0.8% standard rate for auto-debit transactions. Tiered service fee max 0.2% based on average monthly transaction volume (in CNY) on 1688.com.

zyla.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Zyla Enterprise
Description

Enterprise-grade FX and payment solutions with API integration for businesses

zyla.com
+2 more records
Core offering1 text field

Zyla operates a multi-currency digital account and global payment platform that enables U.S. businesses to send and receive international payments, collect earnings from 130+ marketplaces, pay overseas suppliers (including direct CNY payments to China via 1688.com), and access competitive foreign exchange rates. The core Zyla Account is extended through Zyla Enterprise, an API-driven FX and payment solution for institutional and platform clients in financial services, HR/payroll, gig economy, e-commerce, digital entertainment, and travel verticals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 1.5M+ businesses supported since 2004
+1 more record
Product overview1 text field

Zyla offers a single unified product—the Zyla Account—alongside industry-specific solution modules. The Zyla Account is a multi-currency digital wallet providing international payment services including marketplace collections, global supplier payments, and competitive FX rates. This core platform is extended through specialized modules: 1688 World Pay for China payments, Salary Payment in CNY for payroll, and Zyla Enterprise with sector-specific solutions for Financial Institutions, HR & Payroll, Gig Economy, E-commerce, Digital Entertainment, and Airline & Travel industries. The product architecture combines a unified account dashboard with API access and sector-tailored features.

Product and service10 records
1Zyla Account
CategoryMulti-currency Account
Description

Multi-currency digital wallet that enables businesses to send and receive international payments, collect earnings from 130+ marketplaces, pay global suppliers, and access competitive FX rates. Supports 100+ currencies across 210+ countries/territories with local receiving accounts in 17+ currencies.

21688 World Pay
CategoryCross-Border B2B Payment
Description

Joint product with 1688.com (Alibaba) that auto-debits offshore RMB (CNH) from a Zyla Account to pay Chinese suppliers on 1688.com in real time, with no intermediaries. Available exclusively through Zyla.

3Zyla Enterprise
CategoryEnterprise FX & Payments API
Description

Enterprise-grade FX and payments platform with API toolkit, AI-native architecture, and multi-currency fund management, including FX spot, forwards, and Non-Deliverable Forwards (NDFs) for institutional and platform clients.

4Financial Institutions Solution
CategoryEnterprise FX Solution
Description

Institutional-grade FX execution and risk management offering for stock trading platforms, brokerages, and asset managers, with real-time rate locking, dynamic settlement, and API access to FX liquidity.

5HR & Payroll Solution
CategoryEnterprise Payroll Solution
Description

Global payroll service that enables HR and payroll platforms to pay employees in 100+ currencies across 200+ countries/regions via cross-border and local channels, supporting batch payments and e-wallet payouts.

6Gig Economy Solution
CategoryEmbedded Payments Solution
Description

Financial solution for gig economy platforms enabling user payments, service provider payouts, treasury management, and virtual corporate card issuance for ride-hailing, freelance, and online education platforms.

7E-commerce Platform & DTC Solution
CategoryE-commerce Payments Solution
Description

Payment solution for e-commerce sellers and direct-to-consumer platforms enabling collection from 130+ marketplaces in 17+ currencies, FX risk management, and global supplier payments.

8Digital Entertainment Platform Solution
CategoryDigital Entertainment Payments Solution
Description

Payment solution for digital entertainment platforms enabling global payments, multi-currency collections, and contractor payouts.

9Airline & Travel Agency Solution
CategoryTravel Payments Solution
Description

Payment solution for airline and travel agencies enabling global ticket payments, refunds, and multi-currency fund management.

10Salary Payment in CNY
CategoryCNY Payroll Service
Description

Service that enables businesses to make salary payments to employees in China in CNY via Alipay, with employees activating the Quick Collection (闪速收款) service to receive payments directly into their Alipay accounts.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

1688 World Pay is a joint product launched by Zyla and 1688.com for international e-commerce procurement services. Overseas customers can pay for 1688.com orders using Zyla Account while suppliers receive payments in CNY. Zyla is the only payment service provider with this capability, enabling direct real-time CNY payments without intermediaries.

Strategic tierCoreTypeTechnology or Integration
Description

Part of Ant International ecosystem enabling Zyla to leverage Alibaba group infrastructure for China payments. Access to Alipay payment rails and 1688.com marketplace integration.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Related brand under Ant International. Zyla and WorldFirst operate as separate brands but share common ownership and technology infrastructure under Ant International umbrella.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Business funds are held with trusted banking partners that are FDIC members. Banking partners around the world facilitate payment routing to ensure quick delivery to destinations globally.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Connected to 130+ marketplaces including Amazon, TikTok Shop, AliExpress, and others enabling merchants to receive payments directly to Zyla accounts in multiple currencies.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Airwallex provides multi-currency business accounts, FX, and global payments with an API-first model. It directly overlaps Zyla's enterprise FX and SMB multi-currency wallet offering.

TypeDirect peer
Description

Wise is a leading cross-border multi-currency account and remittance platform for consumers and businesses. It competes head-to-head with Zyla on multi-currency wallets, FX spreads, and global payment reach.

TypeDirect peer
Description

Payoneer offers multi-currency accounts and marketplace payouts for SMBs and freelancers. It is a direct competitor for e-commerce sellers collecting from Amazon, TikTok Shop, and similar marketplaces.

TypeDirect peer
Description

WorldFirst is a sister brand under Ant International offering multi-currency accounts and cross-border payments. Operates as a peer brand targeting overlapping SMB and enterprise cross-border use cases.

TypeDirect peer
Description

PingPong provides cross-border payments and FX for e-commerce sellers, with strong China sourcing and marketplace collection capabilities. Closely comparable to Zyla's e-commerce and 1688.com workflows.

TypeBroad incumbent
Description

PayPal offers multi-currency wallets, mass payouts, and FX for businesses globally. It is a broader incumbent with overlapping capabilities but a much wider product portfolio than Zyla.

TypeBroad incumbent
Description

Stripe provides global payment infrastructure including multi-currency processing and Connect for marketplaces. It overlaps with Zyla's API-driven enterprise and marketplace collection offerings.

TypeEmerging player
Description

LianLian Global is a China-based cross-border payment platform serving e-commerce sellers and platforms. Comparable to Zyla for cross-border collection and China supplier payments.

TypeEmerging player
Description

dLocal provides cross-border payment processing focused on emerging markets. Comparable to Zyla's enterprise payout and emerging-market collection use cases for global platforms.

TypeRegional player
Description

Nium is an Asia-headquartered cross-border payments network offering multi-currency accounts and real-time payouts. Comparable in API-first FX and global payout infrastructure, with regional orientation.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Zyla Life Sciences

Cross-Border Paymentszyla.com

Zyla is a US-licensed cross-border payments platform (AUS Merchant Services, Inc., NMLS 1277102) providing a multi-currency account, FX, and 1688.com supplier payments to 1.5M+ SMB and enterprise customers across 210+ countries, operating within the Ant International ecosystem.

What Zyla Life Sciences does

Zyla, operated by AUS Merchant Services, Inc. (NMLS ID: 1277102), is a US-licensed cross-border money transmitter and multi-currency payments platform headquartered at 525 Almanor Ave, Sunnyvale, CA. The company provides a single core product - the Zyla Account, a multi-currency digital wallet supporting 17+ receiving currencies with local account details and 100+ sending currencies across 210+ countries/territories - extended through specialized modules including 1688 World Pay (a 2025-launched joint product with Alibaba's 1688.com enabling real-time CNY payments to Chinese suppliers), Zyla Enterprise (an API-first institutional FX and payments platform), and six vertical-specific solutions targeting E-commerce/DTC, Digital Entertainment, Airline/Travel, Gig Economy, HR/Payroll, and Financial Institutions. The platform is built on a marketed "AI-native architecture" with a smart pricing engine and integrates directly with 130+ marketplaces including Amazon, TikTok Shop, and AliExpress, while bundling FX risk management tools (spot, forwards, NDFs, rate alerts) and Alipay rails for China-bound payments. Zyla sits within the Ant International ecosystem alongside sister brand WorldFirst and partners Alipay+, Antom, and Bettr, sharing technology infrastructure under common ownership.

The business model is transaction-based with no monthly fees or minimum balances. Revenue is generated through per-transaction fees starting at $1 for US bank transfers, currency conversion spreads up to 0.75%, and a 0.8% standard rate plus tiered fees up to 0.2% on 1688 World Pay flows. The customer base spans 1.5M+ businesses accumulated since 2004, segmented into a long tail of SMB e-commerce sellers, software developers, and agencies (acquired via self-serve PLG with online account opening) and a growing enterprise segment (acquired via direct sales and API integration) including named customers BIPO, Grab, and an SFC-licensed stock trading platform. Distribution combines a self-serve SMB funnel (website, SEO, referral program) with enterprise sales motion targeting financial institutions, HR/payroll platforms, and gig economy platforms, supplemented by banking partner networks for fund safeguarding and global payment routing. The company is a FinCEN-registered Money Services Business with state money transmission licenses, restricted in New York and Nevada.

Note on input data: firmographics describe "Zyla Life Sciences" as a 1995-founded healthcare products company in Wayne, PA, but the entirety of the detailed product, customer, revenue, and operational data describes Zyla, a fintech. The analysis above reflects the fintech entity, which is the only subject with substantive evidence in the source material.

Zyla Life Sciences firmographics

Firmographics
Name
Zyla Life Sciences
Legal name
AUS Merchant Services, Inc.
Website
https://zyla.com
Company type
Private
Founded year
1995
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Zyla is a US-licensed cross-border payments platform (AUS Merchant Services, Inc., NMLS 1277102) providing a multi-currency account, FX, and 1688.com supplier payments to 1.5M+ SMB and enterprise customers across 210+ countries, operating within the Ant International ecosystem.
Ownership category
akta.pro rank

Zyla Life Sciences industry classification

Industry
Product category
Cross-Border Payments
NAICS
Activities Related to Credit Intermediation (5223)
SIC
Finance Services (6199)
akta.pro primary industry
Multi-Currency Accounts, Wallets & FX Management (Consumer/SME) (FSAGAKAF)
akta.pro secondary industries
Cross-Border & FX Payments Platforms (BPAMAFAK), Cross-Border Payment Orchestration & Routing (FSAGAKAJ), Cross-border Payments, FX & Multi-currency Checkout (CRAFAJAF)

Keywords

  • Multi-currency payments
  • Cross-border payments
  • Foreign exchange services
  • Global money transfers
  • Payment platform

Where Zyla Life Sciences is headquartered

Location

Headquarters

HQ city
Wayne
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Zyla Life Sciences business model

Business model
GTM type
B2B
Offering type
Software

Revenue model

  1. Transaction Fees: Fees charged per payment transaction to US bank accounts, starting as low as $1 per transaction. Free payments to other Zyla Accounts.
  2. Currency Conversion Spread: Revenue generated from the spread between exchange rates offered to customers and rates received by Zyla. Competitive rates for major currencies including CAD, HKD, AUD, and others.
  3. 1688 World Pay Fees: 0.8% standard rate for auto-debit transactions when paying for 1688.com orders, plus tiered service fee up to 0.2% based on monthly transaction volume

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goMulti-currency account with no monthly fees
Transaction based/ take ratePay-as-you-goPayment fees to US bank accounts
Usage-basedPay-as-you-goCurrency conversion with competitive rates
Transaction based/ take rateMonthly1688 World Pay service fees

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Zyla Life Sciences product offering

Product offering

Core offering

Zyla operates a multi-currency digital account and global payment platform that enables U.S. businesses to send and receive international payments, collect earnings from 130+ marketplaces, pay overseas suppliers (including direct CNY payments to China via 1688.com), and access competitive foreign exchange rates. The core Zyla Account is extended through Zyla Enterprise, an API-driven FX and payment solution for institutional and platform clients in financial services, HR/payroll, gig economy, e-commerce, digital entertainment, and travel verticals.

Product overview

Zyla offers a single unified product—the Zyla Account—alongside industry-specific solution modules. The Zyla Account is a multi-currency digital wallet providing international payment services including marketplace collections, global supplier payments, and competitive FX rates. This core platform is extended through specialized modules: 1688 World Pay for China payments, Salary Payment in CNY for payroll, and Zyla Enterprise with sector-specific solutions for Financial Institutions, HR & Payroll, Gig Economy, E-commerce, Digital Entertainment, and Airline & Travel industries. The product architecture combines a unified account dashboard with API access and sector-tailored features.

Differentiator

Problem solved

Functional benefit

Brands

  • Zyla Enterprise: Enterprise-grade FX and payment solutions with API integration for businesses
  • 1688 World Pay
  • World Card

Products and services

  • Zyla Account Multi-currency digital wallet that enables businesses to send and receive international payments, collect earnings from 130+ marketplaces, pay global suppliers, and access competitive FX rates. Supports 100+ currencies across 210+ countries/territories with local receiving accounts in 17+ currencies.
  • 1688 World Pay Joint product with 1688.com (Alibaba) that auto-debits offshore RMB (CNH) from a Zyla Account to pay Chinese suppliers on 1688.com in real time, with no intermediaries. Available exclusively through Zyla.
  • Zyla Enterprise Enterprise-grade FX and payments platform with API toolkit, AI-native architecture, and multi-currency fund management, including FX spot, forwards, and Non-Deliverable Forwards (NDFs) for institutional and platform clients.
  • Financial Institutions Solution Institutional-grade FX execution and risk management offering for stock trading platforms, brokerages, and asset managers, with real-time rate locking, dynamic settlement, and API access to FX liquidity.
  • HR & Payroll Solution Global payroll service that enables HR and payroll platforms to pay employees in 100+ currencies across 200+ countries/regions via cross-border and local channels, supporting batch payments and e-wallet payouts.
  • Gig Economy Solution Financial solution for gig economy platforms enabling user payments, service provider payouts, treasury management, and virtual corporate card issuance for ride-hailing, freelance, and online education platforms.
  • E-commerce Platform & DTC Solution Payment solution for e-commerce sellers and direct-to-consumer platforms enabling collection from 130+ marketplaces in 17+ currencies, FX risk management, and global supplier payments.
  • Digital Entertainment Platform Solution Payment solution for digital entertainment platforms enabling global payments, multi-currency collections, and contractor payouts.
  • Airline & Travel Agency Solution Payment solution for airline and travel agencies enabling global ticket payments, refunds, and multi-currency fund management.
  • Salary Payment in CNY Service that enables businesses to make salary payments to employees in China in CNY via Alipay, with employees activating the Quick Collection (闪速收款) service to receive payments directly into their Alipay accounts.

Quantifiable outcome

  • 1.5M+ businesses supported since 2004
  • +1 more outcomes

Companies that use Zyla Life Sciences

Customer profile

Named customers3 records

Segments6 records

Zyla Life Sciences technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

Feature5 records

Zyla Life Sciences partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • 1688.com (Alibaba)coreStrategic or Co-development Partner1688 World Pay is a joint product launched by Zyla and 1688.com for international e-commerce procurement services. Overseas customers can pay for 1688.com orders using Zyla Account while suppliers receive payments in CNY. Zyla is the only payment service provider with this capability, enabling direct real-time CNY payments without intermediaries.
  • Alibaba / Ant InternationalcoreTechnology or IntegrationPart of Ant International ecosystem enabling Zyla to leverage Alibaba group infrastructure for China payments. Access to Alipay payment rails and 1688.com marketplace integration.
  • WorldFirstminorStrategic or Co-development PartnerRelated brand under Ant International. Zyla and WorldFirst operate as separate brands but share common ownership and technology infrastructure under Ant International umbrella.
  • FDIC Member Banking PartnerscoreStrategic or Co-development PartnerBusiness funds are held with trusted banking partners that are FDIC members. Banking partners around the world facilitate payment routing to ensure quick delivery to destinations globally.
  • Marketplace Partners (130+)coreChannel Partner/ Reseller/ DistributorConnected to 130+ marketplaces including Amazon, TikTok Shop, AliExpress, and others enabling merchants to receive payments directly to Zyla accounts in multiple currencies.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Zyla Life Sciences competitors and assessment

Company assessment

Direct peers

  • Airwallex: Airwallex provides multi-currency business accounts, FX, and global payments with an API-first model. It directly overlaps Zyla's enterprise FX and SMB multi-currency wallet offering.
  • Wise: Wise is a leading cross-border multi-currency account and remittance platform for consumers and businesses. It competes head-to-head with Zyla on multi-currency wallets, FX spreads, and global payment reach.
  • Payoneer: Payoneer offers multi-currency accounts and marketplace payouts for SMBs and freelancers. It is a direct competitor for e-commerce sellers collecting from Amazon, TikTok Shop, and similar marketplaces.
  • WorldFirst: WorldFirst is a sister brand under Ant International offering multi-currency accounts and cross-border payments. Operates as a peer brand targeting overlapping SMB and enterprise cross-border use cases.
  • PingPong: PingPong provides cross-border payments and FX for e-commerce sellers, with strong China sourcing and marketplace collection capabilities. Closely comparable to Zyla's e-commerce and 1688.com workflows.

Broad incumbents

  • PayPal: PayPal offers multi-currency wallets, mass payouts, and FX for businesses globally. It is a broader incumbent with overlapping capabilities but a much wider product portfolio than Zyla.
  • Stripe: Stripe provides global payment infrastructure including multi-currency processing and Connect for marketplaces. It overlaps with Zyla's API-driven enterprise and marketplace collection offerings.

Emerging players

  • LianLian Global: LianLian Global is a China-based cross-border payment platform serving e-commerce sellers and platforms. Comparable to Zyla for cross-border collection and China supplier payments.
  • dLocal: dLocal provides cross-border payment processing focused on emerging markets. Comparable to Zyla's enterprise payout and emerging-market collection use cases for global platforms.

Regional players

  • Nium: Nium is an Asia-headquartered cross-border payments network offering multi-currency accounts and real-time payouts. Comparable in API-first FX and global payout infrastructure, with regional orientation.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Zyla Life Sciences social profiles

Digital presence

Zyla Life Sciences compliance and trust

Trust signal

Compliance1 record

Zyla Life Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Zyla Life Sciences leadership team

Management profile

Number of profiles

Zyla Life Sciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Zyla Life Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zyla Life Sciences

What does Zyla Life Sciences do?

Zyla operates a multi-currency digital account and global payment platform that enables U.S. businesses to send and receive international payments, collect earnings from 130+ marketplaces, pay overseas suppliers (including direct CNY payments to China via 1688.com), and access competitive foreign exchange rates. The core Zyla Account is extended through Zyla Enterprise, an API-driven FX and payment solution for institutional and platform clients in financial services, HR/payroll, gig economy, e-commerce, digital entertainment, and travel verticals.

Is Zyla Life Sciences a public or private company?

Zyla Life Sciences is a private company. It is classified as corporate owned and is currently operating.

When was Zyla Life Sciences founded?

Zyla Life Sciences was founded in 1995. It employs 5,001 to 10,000 people.

Where is Zyla Life Sciences based?

Zyla Life Sciences is headquartered in Wayne, United States, in the North America region.

How does Zyla Life Sciences make money?

Three revenue lines are on record. Transaction Fees are the primary driver. The others are currency Conversion Spread and 1688 World Pay Fees.

Who are Zyla Life Sciences's main competitors?

Direct peers on record are Airwallex, Wise, Payoneer, WorldFirst and PingPong. Broad incumbents are PayPal and Stripe. Emerging players are LianLian Global and dLocal. Nium is listed as a regional player.

Does Zyla Life Sciences have an API?

Yes. API connection is available for bulk payment uploads and custom system integration. Users can contact the team to get started with API integration for sending more than 25 payments at once.

What industry is Zyla Life Sciences in?

Zyla Life Sciences's product category is Cross-Border Payments. Its primary akta.pro industry code is FSAGAKAF, Multi-Currency Accounts, Wallets & FX Management (Consumer/SME), with a secondary code of BPAMAFAK, Cross-Border & FX Payments Platforms. Its NAICS code is 5223 and its SIC code is 6199.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireAruvant Appoints Stan Musial as Chief Financial OfficerAruvant Sciences appointed Stanley J. Musial as its new Chief Financial Officer, effective immediately, to support the company's substantial growth phase. Musial brings over 25 years of experience in financial strategy and capital fundraising from previous roles at Xenikos B.V., Erydel SpA, and Zyla Life Sciences.PR NewswireAssertio Completed Merger with Zyla Life SciencesAssertio Holdings, Inc. completed its merger with Zyla Life Sciences on May 20, 2020, creating a combined specialty pharmaceutical company focused on neurology, inflammation, and pain products that trades on Nasdaq under ticker ASRT. The merged entity projects pro forma 2019 net product sales of approximately $128 million, non-GAAP adjusted EBITDA margin exceeding 25% for 2020, and anticipates more than $40 million in cost synergies. The combined company holds eight branded, FDA-approved non-steroidal anti-inflammatory drug products and positions itself to capitalize on trends toward non-opioid pain treatments.PR NewswireZyla Life Sciences Reports First Quarter 2020 Financial ResultsZyla Life Sciences reported Q1 2020 financial results with net product sales of $19.1 million, up 9% from $17.6 million in Q1 2019, driven by 25% volume growth in SPRIX Nasal Spray and 11% growth in INDOCIN net product sales over Q4 2019. The company announced a proposed merger with Assertio Therapeutics on March 16, 2020, expected to close in Q2 2020 pending stockholder approvals, with combined pro-forma 2019 revenue of approximately $128 million and synergy potential of up to $40 million. Zyla reported a net loss of $18.2 million for Q1 2020 and generated positive cash flow of $2.6 million, while monitoring COVID-19 impacts on supply chain and patient access.PR NewswireZyla Life Sciences to Host Conference Call and Webcast to Discuss First Quarter 2020 Financial Results on May 15, 2020Zyla Life Sciences announced its 2020 first quarter financial results will be released on May 15, 2020, followed by a management conference call and webcast at 8:30 a.m. Eastern Time to review financial and operating results. The company also scheduled a virtual Special Meeting for May 19, 2020 at 10:00 a.m. Eastern Time to obtain stockholder approval for the proposed merger with Assertio Therapeutics, Inc. The merger, announced on March 16, 2020, would combine Assertio with Zyla as a wholly owned subsidiary and is expected to close in Q2 2020 subject to stockholder approvals and customary closing conditions.GlobeNewswireAssertio Therapeutics Announces its Virtual 2020 Annual Meeting on May 19, 2020, and Mailing of its Joint Proxy Statement/ProspectusAssertio Therapeutics announced its 2020 annual meeting will be held virtually on May 19, 2020, and mailed a joint proxy statement/prospectus for the merger with Zyla Life Sciences. The merger is expected to close shortly after the meetings, with Q1 2020 financial results to be released on May 11, 2020.PR NewswireZyla Life Sciences Reports Fourth Quarter and Full Year 2019 Financial ResultsZyla Life Sciences reported fourth quarter and full year 2019 financial results, with full-year net product sales of $81.3 million in line with guidance and Q4 2019 sales of $19.3 million, representing a 227% increase over Q4 2018 due to the expanded product portfolio from the Iroko acquisition. The company achieved positive adjusted EBITDA of $9.4 million for 2019 and reported net income of $60.6 million driven by reorganization items. The company also announced a proposed merger with Assertio Therapeutics on March 16, 2020, expected to close in Q2 2020, pending stockholder and regulatory approvals.GlobeNewswireAssertio Therapeutics Agrees to Merge with Zyla Life Sciences to Create Synergistic Portfolio of Neurology and Non-Opioid Pain ProductsAssertio Therapeutics and Zyla Life Sciences entered a definitive merger agreement, with Zyla stockholders receiving 2.5 new shares per share. The combined company expects pro forma 2019 net product sales of about $128 million and cost synergies of over $40 million. The merger is expected to close in the second quarter of 2020.PR NewswireZyla Life Sciences to Host Conference Call and Webcast to Discuss Year End 2019 Financial Results on March 27, 2020Zyla Life Sciences, a commercial-stage life sciences company headquartered in Wayne, Pennsylvania, announced it will release its year-end 2019 financial results on March 27, 2020, followed by a live conference call and webcast at 8:30 a.m. Eastern Time to review financial and operating results and provide a business update. The call will be accessible via the company's website or by telephone using provided dial-in numbers. Zyla's portfolio includes six products for pain and inflammation: SPRIX, ZORVOLEX, VIVLODEX, INDOCIN oral suspension and suppositories, and OXAYDO.PR NewswireZyla Life Sciences to Host Conference Call and Webcast to Discuss Third Quarter 2019 Financial Results on November 14, 2019Zyla Life Sciences announced that its third quarter 2019 financial results will be released on Thursday, November 14, 2019, with management hosting a live conference call and webcast at 4:30 p.m. Eastern Time to review the company's financial and operating results. The commercial-stage life sciences company focuses on marketing treatments for pain and inflammation, with a portfolio of seven products including SPRIX, ZORVOLEX, VIVLODEX, TIVORBEX, INDOCIN, and OXAYDO. The announcement includes standard forward-looking statement disclaimers and investor relations contact information.PR NewswireZyla Life Sciences to Present at and Participate in a Panel at the 2019 Disruptive Growth Conference on September 5, 2019Zyla Life Sciences announced that its president and CEO Bob Radie will give a corporate presentation and participate in a panel at the 2019 Disruptive Growth Conference in New York City on September 5, 2019. The presentation will review Zyla's commercial product portfolio for pain and inflammation, including SPRIX, VIVLODEX, TIVORBEX, ZORVOLEX, INDOCIN products, and OXAYDO. Zyla is a commercial-stage life sciences company focused on marketing pain and inflammation products and is seeking to acquire additional product candidates or approved products.